These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

383 related items for PubMed ID: 11408610

  • 1. Evidence for a new G protein-coupled cannabinoid receptor in mouse brain.
    Breivogel CS, Griffin G, Di Marzo V, Martin BR.
    Mol Pharmacol; 2001 Jul; 60(1):155-63. PubMed ID: 11408610
    [Abstract] [Full Text] [Related]

  • 2. Structure-activity relationship for the endogenous cannabinoid, anandamide, and certain of its analogues at vanilloid receptors in transfected cells and vas deferens.
    Ross RA, Gibson TM, Brockie HC, Leslie M, Pashmi G, Craib SJ, Di Marzo V, Pertwee RG.
    Br J Pharmacol; 2001 Feb; 132(3):631-40. PubMed ID: 11159715
    [Abstract] [Full Text] [Related]

  • 3. Evidence that the plant cannabinoid Delta9-tetrahydrocannabivarin is a cannabinoid CB1 and CB2 receptor antagonist.
    Thomas A, Stevenson LA, Wease KN, Price MR, Baillie G, Ross RA, Pertwee RG.
    Br J Pharmacol; 2005 Dec; 146(7):917-26. PubMed ID: 16205722
    [Abstract] [Full Text] [Related]

  • 4. Cannabinoid pharmacology: implications for additional cannabinoid receptor subtypes.
    Wiley JL, Martin BR.
    Chem Phys Lipids; 2002 Dec 31; 121(1-2):57-63. PubMed ID: 12505690
    [Abstract] [Full Text] [Related]

  • 5. Cannabinoid receptor stimulation of guanosine-5'-O-(3-[35S]thio)triphosphate binding in rat brain membranes.
    Selley DE, Stark S, Sim LJ, Childers SR.
    Life Sci; 1996 Dec 31; 59(8):659-68. PubMed ID: 8761016
    [Abstract] [Full Text] [Related]

  • 6. Antiemetic and motor-depressive actions of CP55,940: cannabinoid CB1 receptor characterization, distribution, and G-protein activation.
    Darmani NA, Sim-Selley LJ, Martin BR, Janoyan JJ, Crim JL, Parekh B, Breivogel CS.
    Eur J Pharmacol; 2003 Jan 10; 459(1):83-95. PubMed ID: 12505537
    [Abstract] [Full Text] [Related]

  • 7. Loss of cannabinoid-stimulated guanosine 5'-O-(3-[(35)S]Thiotriphosphate) binding without receptor down-regulation in brain regions of anandamide-tolerant rats.
    Rubino T, Viganò D, Costa B, Colleoni M, Parolaro D.
    J Neurochem; 2000 Dec 10; 75(6):2478-84. PubMed ID: 11080200
    [Abstract] [Full Text] [Related]

  • 8. Endocannabinoid 2-arachidonyl glycerol is a full agonist through human type 2 cannabinoid receptor: antagonism by anandamide.
    Gonsiorek W, Lunn C, Fan X, Narula S, Lundell D, Hipkin RW.
    Mol Pharmacol; 2000 May 10; 57(5):1045-50. PubMed ID: 10779390
    [Abstract] [Full Text] [Related]

  • 9. In vitro autoradiography of receptor-activated G proteins in rat brain by agonist-stimulated guanylyl 5'-[gamma-[35S]thio]-triphosphate binding.
    Sim LJ, Selley DE, Childers SR.
    Proc Natl Acad Sci U S A; 1995 Aug 01; 92(16):7242-6. PubMed ID: 7638174
    [Abstract] [Full Text] [Related]

  • 10. Autoradiographic analysis of cannabinoid receptor binding and cannabinoid agonist-stimulated [35S]GTP gamma S binding in morphine-dependent mice.
    Romero J, Fernández-Ruiz JJ, Vela G, Ruiz-Gayo M, Fuentes JA, Ramos JA.
    Drug Alcohol Depend; 1998 May 01; 50(3):241-9. PubMed ID: 9649978
    [Abstract] [Full Text] [Related]

  • 11. Cannabinoid CB(1) receptor expression, activation and detection of endogenous ligand in trabecular meshwork and ciliary process tissues.
    Stamer WD, Golightly SF, Hosohata Y, Ryan EP, Porter AC, Varga E, Noecker RJ, Felder CC, Yamamura HI.
    Eur J Pharmacol; 2001 Nov 23; 431(3):277-86. PubMed ID: 11730719
    [Abstract] [Full Text] [Related]

  • 12. Dysregulation of the endogenous cannabinoid system in adult rats prenatally treated with the cannabinoid agonist WIN 55,212-2.
    Castelli MP, Paola Piras A, D'Agostino A, Pibiri F, Perra S, Gessa GL, Maccarrone M, Pistis M.
    Eur J Pharmacol; 2007 Nov 14; 573(1-3):11-9. PubMed ID: 17644084
    [Abstract] [Full Text] [Related]

  • 13. Enhancement of anandamide formation in the limbic forebrain and reduction of endocannabinoid contents in the striatum of delta9-tetrahydrocannabinol-tolerant rats.
    Di Marzo V, Berrendero F, Bisogno T, González S, Cavaliere P, Romero J, Cebeira M, Ramos JA, Fernández-Ruiz JJ.
    J Neurochem; 2000 Apr 14; 74(4):1627-35. PubMed ID: 10737621
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Activation of brain-type cannabinoid receptors interferes with preimplantation mouse embryo development.
    Yang ZM, Paria BC, Dey SK.
    Biol Reprod; 1996 Oct 14; 55(4):756-61. PubMed ID: 8879486
    [Abstract] [Full Text] [Related]

  • 17. Interaction of anandamide with the M(1) and M(4) muscarinic acetylcholine receptors.
    Christopoulos A, Wilson K.
    Brain Res; 2001 Oct 05; 915(1):70-8. PubMed ID: 11578621
    [Abstract] [Full Text] [Related]

  • 18. Inhibitory effects of SR141716A on G-protein activation in rat brain.
    Sim-Selley LJ, Brunk LK, Selley DE.
    Eur J Pharmacol; 2001 Mar 02; 414(2-3):135-43. PubMed ID: 11239913
    [Abstract] [Full Text] [Related]

  • 19. Cannabinoid receptor and WIN-55,212-2-stimulated [35S]GTP gamma S binding and cannabinoid receptor mRNA levels in the basal ganglia and the cerebellum of adult male rats chronically exposed to delta 9-tetrahydrocannabinol.
    Romero J, Berrendero F, García-Gil L, Ramos JA, Fernández-Ruiz JJ.
    J Mol Neurosci; 1998 Oct 02; 11(2):109-19. PubMed ID: 10096037
    [Abstract] [Full Text] [Related]

  • 20. The psychoactive plant cannabinoid, Delta9-tetrahydrocannabinol, is antagonized by Delta8- and Delta9-tetrahydrocannabivarin in mice in vivo.
    Pertwee RG, Thomas A, Stevenson LA, Ross RA, Varvel SA, Lichtman AH, Martin BR, Razdan RK.
    Br J Pharmacol; 2007 Mar 02; 150(5):586-94. PubMed ID: 17245367
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.